Centene Corp (CNC) concluded trading on Wednesday at a closing price of $60.54, with 3.76 million shares of worth about $227.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.65% during that period and on March 26, 2025 the price saw a gain of about 2.71%. Currently the company’s common shares owned by public are about 495.91M shares, out of which, 489.96M shares are available for trading.
Stock saw a price change of 2.21% in past 5 days and over the past one month there was a price change of -1.29%. Year-to-date (YTD), CNC shares are showing a performance of -0.07% which decreased to -21.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $55.03 but also hit the highest price of $80.59 during that period. The average intraday trading volume for Centene Corp shares is 4.49 million. The stock is currently trading 2.66% above its 20-day simple moving average (SMA20), while that difference is up 0.60% for SMA50 and it goes to -7.92% lower than SMA200.
Centene Corp (NYSE: CNC) currently have 495.91M outstanding shares and institutions hold larger chunk of about 97.44% of that.
The stock has a current market capitalization of $30.03B and its 3Y-monthly beta is at 0.56. PE ratio of stock for trailing 12 months is 9.69, while it has posted earnings per share of $6.25 in the same period. Its PEG reads 1.05 while making debt-to-equity ratio of 0.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CNC, volatility over the week remained 2.50% while standing at 3.16% over the month.
Stock’s fiscal year EPS is expected to rise by 1.65% while it is estimated to increase by 10.83% in next year. EPS is likely to shrink at an annualized rate of 9.21% for next 5-years, compared to annual growth of 14.96% made by the stock over the past 5-years.
Coverage by JP Morgan stated Centene Corp (CNC) stock as an Overweight in their note to investors on December 17, 2024, suggesting a price target of $75 for the stock. On December 13, 2024, UBS Upgrade their recommendations, while on December 10, 2024, Jefferies Downgrade their ratings for the stock with a price target of $52. Stock get a Hold rating from Jefferies on July 24, 2024.
